Edition:
India

People: SSY Group Ltd (2005.HK)

2005.HK on Hong Kong Stock

6.29HKD
18 Dec 2018
Change (% chg)

HK$-0.17 (-2.63%)
Prev Close
HK$6.46
Open
HK$6.38
Day's High
HK$6.48
Day's Low
HK$6.26
Volume
2,351,663
Avg. Vol
4,951,592
52-wk High
HK$9.46
52-wk Low
HK$4.62

Su, Xuejun 

Mr. Su Xuejun serves as Executive Director of the Company. Mr. Su is responsible for marketing and management functions of Shijiazhuang No.4 Pharma, the Company’s wholly-owned subsidiary. Mr. Su joined No.1 Pharma as assistant to factory manager in 1990. And afterwards he served as deputy general manager of a subsidiary of the Shijiazhuang Pharmaceutical Group selling preparations. Since January 2002, Mr. Su acts as deputy general manager of Shijiazhuang No.4 Pharma. Since January 2007, Mr. Su acts as executive director of Shijiazhuang No.4 Pharma and New Orient. Since July 2013, Mr. Su acts as deputy chairman of Shijiazhuang No.4 Pharma. Mr. Su graduated from Hebei Normal University, majoring in biology, with a bachelor’s degree. He focuses in the pharmaceutical market development, operations and management. He has extensive understanding and experience in the marketing and the policy in the related industries.

Basic Compensation

Total Annual Compensation, HKD 986,000
Restricted Stock Award, HKD --
Long-Term Incentive Plans, HKD --
All Other, HKD 40,000
Fiscal Year Total, HKD 1,026,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Jiguang Qu

11,960,000

Hing Yeung Chow

--

Xuejun Su

1,026,000

Xianjun Wang

1,800,000

Hao Feng

15,000

Kwok Wai Chow

180,000
As Of  31 Dec 2017